| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/21/2011 | US20110092503 Quinoline derivatives as axl kinase inhibitors |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092495 Compounds for the treatment of multi-drug resistant bacterial infections |
| 04/21/2011 | US20110092488 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections |
| 04/21/2011 | US20110092481 Quinoline or isoquinoline substituted p2x7 antagonists |
| 04/21/2011 | US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions |
| 04/21/2011 | US20110092475 2-substituted-ethynylthiazole derivatives and uses of same |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092461 Pyridyl inhibitors of hedgehog signalling |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110090338 Vehicular rearview mirror system |
| 04/21/2011 | CA2777782A1 Sepiapterin reductase inhibitors for the treatment of pain |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2777518A1 Cgrp receptor antagonists |
| 04/21/2011 | CA2777509A1 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system |
| 04/21/2011 | CA2777043A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 04/21/2011 | CA2776543A1 Inhibitors of bruton's tyrosine kinase |
| 04/21/2011 | CA2776457A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/21/2011 | CA2774512A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/20/2011 | EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/20/2011 | EP2311823A1 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| 04/20/2011 | EP2311822A1 Gpr119 agonist |
| 04/20/2011 | EP2311821A1 Polymorphic form of Imatinib mesylate and processes for its preparation |
| 04/20/2011 | EP2311814A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| 04/20/2011 | EP2311810A1 Amidine derivative |
| 04/20/2011 | EP2311809A1 Quinolinyloxyphenylsulfonamides |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311801A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2011 | EP2310383A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 04/20/2011 | EP2310382A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 04/20/2011 | EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 04/20/2011 | EP2310375A1 Chemical compounds |
| 04/20/2011 | EP2310374A1 Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |
| 04/20/2011 | EP2310012A1 Process for the preparation of substituted pyrimidine derivatives |
| 04/20/2011 | EP2309857A2 Heterocyclic compounds used as pesticides |
| 04/20/2011 | EP2220070B1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 04/20/2011 | EP1928835B1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 04/20/2011 | EP1784396B8 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 04/20/2011 | EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors |
| 04/20/2011 | EP1546100B1 New benzoyl piperidine compounds |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | CN1845902B Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives |
| 04/20/2011 | CN102026997A Insecticidal compounds |
| 04/20/2011 | CN102026996A Pyridazine derivatives as factor XIA inhibitors |
| 04/20/2011 | CN102026995A 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 04/20/2011 | CN102026994A Crystal of benzimidazole compound |
| 04/20/2011 | CN102026993A New compounds III |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/20/2011 | CN102026980A Isoquinolinone derivatives as NK3 antagonists |
| 04/20/2011 | CN102026978A Pyridine compounds |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/20/2011 | CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods |
| 04/20/2011 | CN102020639A 6-amido quinazoline or 3-cyano quinoline derivative, preparation method thereof and application of derivative to medicament |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020637A Preparation method of 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole |
| 04/20/2011 | CN102020636A Method for synthesizing and purifying Fasudil hydrochloride |
| 04/20/2011 | CN102020635A Preparation method of hydrochloride Fasudil hemihydrate |
| 04/20/2011 | CN102020634A Preparation method of N-(w-cyanoalkyl) benzamide compounds |
| 04/20/2011 | CN102020633A Method for preparing 1-(3,5- dichloropyridine-2-yl)-pyrazolecarboxamide compounds |
| 04/20/2011 | CN101314595B Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/20/2011 | CN101010299B Six-membered heterocycles useful as serine protease inhibitors |
| 04/20/2011 | CN101001851B Hydroxyamide compounds having activity as inhibitors of histone deacetylase (HDAC) |
| 04/19/2011 | US7928241 Stereoselective synthesis of benzimidazole sulfoxides |
| 04/19/2011 | US7928240 Process for preparation of substituted sulfoxides |
| 04/19/2011 | US7928239 Anticarcinogenic agents |
| 04/19/2011 | US7928233 Spiroindolinone pyridine derivatives |
| 04/19/2011 | US7928230 Method for modulating GPR119 G protein-coupled receptor and selected compounds |
| 04/19/2011 | US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928133 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/19/2011 | US7928131 Imidazole compounds |
| 04/19/2011 | US7928126 Cyanopyridine derivative and use thereof as medicine |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928122 Modulators of cellular adhesion |
| 04/19/2011 | US7928121 2-[1-(5-Chloro-2,4-difluoro-benzenesulfonyl)-piperidin-4-ylmethyl]-1,2,3,4-tetrahydroisoquinolinehydrochloride; antidepressant, anxiolytic, hypotensive agent; psychosis, schizophrenia, migraine, cognition activity; pharmacokinetics |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928110 Pyrimidine compound and pests controlling composition containing the same |
| 04/19/2011 | US7928108 Pyridinone derivative for the treatment of premature ejaculation |
| 04/19/2011 | US7928104 Enhances sensitivity to radiotherapy and chemotherapy; synergistic; hydrolysis of a 2-methoxyquinoline or 2-methoxyquinoxaline; cyclization of a N-phenyl phenylacrylamide; or condensation of an o-benzenediamine with a keto-ester; preferred oxalate salt; side effect reduction |
| 04/19/2011 | CA2640482C Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2621181C 5-isoquinolinesulfonamide compounds |
| 04/19/2011 | CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/19/2011 | CA2578047C Phenylaminopyridines |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |